Ambry Genetics

Overview

Ambry Genetics operates within the manufacturing sector, specifically in the biotechnology and pharmaceuticals industry, and has been active since its founding in 1999. The company specializes in genetic testing and provides clinical management guidelines based on genetic predispositions to various conditions, including myeloid neoplasms and tuberous sclerosis complex. Their published documents include practical tips for managing genetic conditions and research articles that explore the role of genetic data in clinical decision-making. Notably, Ambry Genetics has developed a Gene-Disease Validity (GDV) scoring system to assess the strength of associations between specific genes and diseases, which aids in hereditary cancer testing. The company’s research emphasizes the importance of multigene panel tests in improving diagnostic yields while addressing challenges related to variants of uncertain significance. Through their documentation, Ambry Genetics aims to inform healthcare providers about the implications of genetic testing and enhance patient management strategies based on genetic findings.

Industry